C4 Therapeutics (CCCC) FCF Margin (QoQ) (2020 - 2026)
C4 Therapeutics (CCCC) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | C4 Therapeutics | 460.17 Mn | 224.50 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28,104.00 |
| Dec 31, 2025 | 7,016.00 |
| Sep 30, 2025 | -8,705.00 |
| Jun 30, 2025 | 27,045.00 |
| Mar 31, 2025 | -11,356.00 |
| Dec 31, 2024 | -18,809.00 |
| Sep 30, 2024 | -11,667.00 |
| Jun 30, 2024 | 55,465.00 |
| Mar 31, 2024 | 14,488.00 |
| Dec 31, 2023 | -45,830.00 |
| Sep 30, 2023 | 44,393.00 |
| Jun 30, 2023 | 17,020.00 |
| Mar 31, 2023 | 17,592.00 |
| Dec 31, 2022 | -60,901.00 |
| Sep 30, 2022 | -29,954.00 |
| Jun 30, 2022 | 18,546.00 |
| Mar 31, 2022 | -22,187.00 |
| Dec 31, 2021 | 7,438.00 |
| Sep 30, 2021 | -1,362.00 |
| Jun 30, 2021 | 15,688.00 |